-+ 0.00%
-+ 0.00%
-+ 0.00%

OKYO Pharma Reports Phase 2 Trial Shows Urcosimod Improves Corneal Nerve Health in Neuropathic Corneal Pain

Reuters·12/11/2025 13:30:32

Please log in to view news